AUS
NZ
UK
CA
USA
IND
Health
Kymera Therapeutics (NASDAQ:KYMR) Nasdaq Composite ETF Protein Regulation
January 08, 2026 12:00 AM PST| By Anmol KhazanchiKymera Therapeutics focuses on small-molecule therapies targeting protein homeostasis pathways, appearing in broader biotechnology discussions where the nasdaq composite etf is mentioned in market coverage.
Neogen (NASDAQ:NEOG) Nasdaq Index Fund Compliance Systems
January 08, 2026 12:00 AM PST| By Anmol KhazanchiNeogen Corporation provides food and animal safety diagnostics worldwide, supporting pathogen and toxin detection while appearing in broader financial conversations where the nasdaq index fund is mentioned.
Gilead Sciences (NASDAQ:GILD) Nasdaq 100 Index Biopharma Scale
January 07, 2026 12:00 AM PST| By Anmol KhazanchiGilead Sciences operates a global biopharmaceutical platform focused on antiviral, oncology, and cell therapy research, appearing in broader healthcare discussions linked to companies within the nasdaq 100 index.
Neogen Corporation (NASDAQ:NEOG) Nasdaq Composite Biosecurity Role
January 07, 2026 12:00 AM PST| By Anmol KhazanchiNeogen Corporation (NASDAQ:NEOG) delivers food and animal safety testing solutions worldwide, maintaining visibility in broader market discussions where the nasdaq composite highlights science-driven companies.
Royalty Pharma plc (NASDAQ:RPRX) Nasdaq Index Life Sciences Partner
January 07, 2026 12:00 AM PST| By Anmol KhazanchiRoyalty Pharma plc focuses on acquiring biopharmaceutical royalty interests and revenue rights, maintaining visibility in market discussions that include the nasdaq 100 index within broader financial narratives.
Compass Pathways (Nasdaq:CMPS) Enters Strategic Collaboration with Radial Health
January 06, 2026 11:47 PM PST| By Team Kalkine MediaHighlights,Compass Pathways has entered its seventh U.S. strategic collaboration with Radial Health.,Radial Health operates in five states and provides virtual mental health assessments nationwide.,The partnership aims to inform scalable delivery mod...
Astrana Health (NASDAQ:ASTH) Nasdaq Futures Frame Digital Care Delivery
January 06, 2026 12:00 AM PST| By Anmol KhazanchiAstrana Health (NASDAQ:ASTH) delivers physician-centric care coordination through technology-enabled platforms, appearing in broader healthcare discussions shaped by themes linked to nasdaq futures.
AtriCure, Inc. (NASDAQ:ATRC) Nasdaq Index Fund Medical Devices
January 06, 2026 12:00 AM PST| By Anmol KhazanchiAtriCure (NASDAQ:ATRC) develops innovative medical devices for atrial fibrillation and related conditions, maintaining visibility in broader healthcare discussions where the nasdaq index fund is mentioned.
Sotera Health Inc (NASDAQ:SHC) Nasdaq Futures Quality Systems
January 06, 2026 12:00 AM PST| By Anmol KhazanchiHighlights,Global sterilization services support regulated industries,Laboratory testing strengthens compliance frameworks,nasdaq futures discussions include healthcare service providers,Sotera Health Inc (NASDAQ:SHC) operates as a specialized health...
Janux Therapeutics (NASDAQ:JANX) Nasdaq 100 Index Biotech Innovator
January 06, 2026 12:00 AM PST| By Anmol KhazanchiJanux Therapeutics (NASDAQ:JANX) advances next-generation immuno-oncology through proprietary TLR agonists, maintaining visibility in biotechnology conversations where the nasdaq 100 index is often discussed.
Maravai LifeSciences (NASDAQ:MRVI) Nasdaq Index Life Sciences Inputs
January 06, 2026 12:00 AM PST| By Anmol KhazanchiMaravai LifeSciences (NASDAQ:MRVI) enables biologic research and genomic workflows through specialized reagents, appearing in broader market discussions connected to the nasdaq index and life sciences infrastructure.
Sana Biotechnology (NASDAQ:SANA) shaping Nasdaq 100 composition
January 06, 2026 12:00 AM PST| By Anmol KhazanchiSana Biotechnology develops engineered cell therapies using gene editing and delivery technologies, appearing in broader biotechnology discussions shaped by themes linked to the nasdaq 100 composition.
Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) Nasdaq Futures Pipeline Depth
January 05, 2026 12:00 AM PST| By Anmol KhazanchiIronwood Pharmaceuticals focuses on gastrointestinal treatments through its commercial-stage portfolio, including LINZESS, while appearing in broader biotech conversations shaped by movements linked to Nasdaq futures.
GH Research Holdings Inc (NASDAQ:GHRS) Nasdaq Composite ETF Biotech Scope
January 05, 2026 12:00 AM PST| By Anmol KhazanchiGH Research Holdings Inc (NASDAQ:GHRS) advances psychedelic-inspired therapies for neuropsychiatric disorders, appearing in broader biotechnology discussions connected to the nasdaq composite etf.
Merck & Co., Inc. (NYSE:MRK) S&P 500 Fund Pharma Positioning
January 05, 2026 12:00 AM PST| By Anmol KhazanchiMerck & Co. Inc operates across pharmaceuticals, vaccines, biologics, and animal health, maintaining global healthcare relevance while appearing in broader market discussions connected to the s&p 500 fund.
Johnson & Johnson (NYSE:JNJ) S&P 500 Today Pharma Leadership
January 05, 2026 12:00 AM PST| By Anmol KhazanchiJohnson & Johnson operates across pharmaceuticals and medical technology, maintaining global healthcare presence while appearing in broader market discussions shaped by themes associated with s&p 500 today.
Abbott Laboratories (NYSE:ABT) Healthcare Weight In S&P 500 Chart
January 05, 2026 12:00 AM PST| By Anmol KhazanchiAbbott Laboratories, a global healthcare leader, develops and markets a wide range of medical products and services, and frequently appears in discussions where the s&p 500 chart is included in broader financial context.
Veeva Systems (NYSE:VEEV) Stock Tracks Russell 1000 Index Composite
January 02, 2026 07:01 AM PST| By Anmol KhazanchiThis article outlines Veeva Systems Inc. software focus, disclosure practices, and market context, highlighting enterprise technology operations and Russell 1000 index alignment.
Owlet Baby Care (NYSE:OWLT) Shares Unchanged in NYSE Composite
January 02, 2026 06:35 AM PST| By Anmol KhazanchiArticle reviews Owlet Baby Care, Inc activities in consumer health technology, product development focus, disclosure environment, operational structure, and NYSE Composite classification context.
Merck & Co (NYSE:MRK) Sees Institutional Ownership Changes Filed
January 02, 2026 05:49 AM PST| By Anmol KhazanchiArticle outlines Merck & Co., Inc. pharmaceutical operations, ownership disclosures, governance context, and market index classification within the NYSE Composite and russell 1000 environment.
